KZA kazia therapeutics limited

News: KZA Kazia Therapeutics Says U.S. FDA Grants Rare Pediatric Disease Designation To Paxalisib

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Aug 7 (Reuters) - Kazia Therapeutics Ltd (KZA) :

    • US FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION TO PAXALISIB FOR DIFFUSE INTRINSIC PONTINE GLIOMA
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.